Oncogenic chromodomain mutations allosterically impair TIP60 acetyltransfearse function preventing activation of DNA repair genes under genotoxic stress

This study reveals that cancer-associated mutations in the TIP60 chromodomain allosterically disrupt its trimeric assembly and acetyl-CoA docking, thereby impairing histone acetyltransferase activity and the subsequent activation of DNA repair genes under genotoxic stress.

The Gist

The Big Picture: A Broken Factory Manager

Imagine your cell is a bustling factory. Inside this factory, there is a very important manager named TIP60.

TIP60's main job is to act as a "repair foreman." When the factory gets damaged (for example, by UV light or radiation, which we call "genotoxic stress"), TIP60 needs to:

1. Find the damage (locate the broken machinery).
2. Call the repair crew (turn on specific genes like p21 that stop the factory from running so repairs can happen).
3. Do the actual work (using a special tool called an "acetyltransferase" to fix the molecular switches).

The paper discovers that in some cancers, TIP60 has a specific type of damage. It's not that TIP60 can't find the broken machinery, and it's not that it can't get to the repair site. Instead, its internal gears have jammed, so it can't actually do the repair work.

---

The Two Parts of the Manager

To understand the problem, we need to look at TIP60's "uniform," which has two main parts:

1. The "Eyes" (The Chromodomain): This is the part at the front of TIP60. Its job is to read the "labels" on the factory walls (histone modifications) to know exactly where to stand.
2. The "Hands" (The MYST Domain): This is the part at the back. This is the engine that does the actual work (acetylating histones) to fix the DNA.

Usually, scientists thought that if the "Eyes" were broken, the manager would just wander around aimlessly and never find the broken machine.

The Surprise: This paper found that in cancer, the "Eyes" are actually fine! The manager can still see the broken machine and stand right next to it. But, strangely, the "Hands" refuse to work.

---

The Culprits: R53H and R62W

The researchers looked at cancer patients and found two specific typos (mutations) in the instructions for TIP60's "Eyes":

• R53H
• R62W

Think of these like typos in a blueprint. One letter changed in the code, turning an "Arginine" (a specific amino acid) into a "Histidine" or a "Tryptophan."

The Mechanism: The "Three-Legged Stool" Analogy

Here is the most important discovery of the paper, explained with an analogy:

The Trimeric Assembly:
TIP60 doesn't work alone. To function, three TIP60 managers must hold hands and form a three-legged stool (a trimer).

• The Legs: The three managers link up.
• The Seat: The middle of the stool is where the "repair tool" (Acetyl-CoA) sits.

What went wrong?
The researchers found that these two mutations (R53H and R62W) act like a hidden crack in the legs of the stool.

• R53H: The stool still looks like a stool, but the legs are wobbly. The tool can't sit still.
• R62W: This is worse. The mutation changes the shape of the legs so much that the "seat" (where the tool sits) collapses. The tool falls off immediately.

The Result:
Even though TIP60 is standing in the right place (the chromatin), the three-legged stool is unstable. The "repair tool" (Acetyl-CoA) cannot dock properly. Without the tool, TIP60 cannot turn on the p21 gene.

The Consequence: A Factory That Won't Stop

When the factory (cell) gets damaged, it needs to hit the "Emergency Stop" button (the p21 gene) to pause production and fix the damage.

• Normal TIP60: Sees damage $\rightarrow$ Forms a stable stool $\rightarrow$ Grabs the tool $\rightarrow$ Turns on the "Stop" button $\rightarrow$ Cell pauses and repairs itself.
• Mutant TIP60: Sees damage $\rightarrow$ Stands in the right spot $\rightarrow$ But the stool collapses. The tool falls off. The "Stop" button is never pressed.

The Tragedy: The factory keeps running while it's broken. The cell keeps dividing with damaged DNA. This leads to more mutations, and eventually, cancer.

Summary in One Sentence

The paper reveals that certain cancer mutations in TIP60 don't stop the protein from finding the damage; instead, they break the protein's internal "three-legged stool," causing it to drop its repair tools and fail to stop the cell cycle, which allows cancer to grow.

Technical Summary

1. Problem Statement

TIP60 (KAT5) is a critical tumor suppressor and histone acetyltransferase (HAT) essential for DNA damage repair, apoptosis, and transcriptional regulation. It possesses an N-terminal chromodomain (CD) for chromatin binding and a C-terminal MYST domain for catalytic activity. While missense mutations in chromodomains are frequently observed in cancer, the prevailing assumption is that they primarily disrupt chromatin binding. However, the functional consequences of specific TIP60 chromodomain mutations on its enzymatic activity and oligomerization remain poorly understood. This study investigates whether cancer-associated mutations in the TIP60 chromodomain impair its catalytic function through mechanisms other than simple loss of chromatin localization.

2. Methodology

The study employed a multi-disciplinary approach combining bioinformatics, structural biology, molecular dynamics, and cell biology:

• Data Mining & Prediction: Missense mutations in the TIP60 chromodomain were identified from cBioPortal and the COSMIC database. Six overlapping mutations were selected. Deleteriousness and stability impacts were predicted using PredictSNP (integrating MAPP, PolyPhen, SIFT, etc.) and stability tools (I-Mutant 2.0, SAAFEC-SEQ, INPS).
• Structural Modeling & Molecular Dynamics (MD):
  • The TIP60 chromodomain (residues 1–78) was modeled using RoseTTAFold and refined with GalaxyRefine.
  • MD Simulations: 500-nanosecond simulations were performed using Desmond (TIP3P water model, NPT ensemble at 300K) to analyze conformational stability, Root-Mean-Square Deviation (RMSD), Radius of Gyration (Rg), Solvent Accessible Surface Area (SASA), and intramolecular hydrogen bonding.
• In Silico Oligomerization & Docking:
  • Full-length TIP60 trimeric models were generated using GalaxyHomomer.
  • Molecular docking (CDocker) was performed to assess the binding affinity of acetyl-CoA and other acyl-CoA cofactors to wild-type (WT) and mutant (R53H, R62W) trimers.
• Experimental Validation:
  • Cloning & Expression: Mutants R53H and R62W were generated via site-directed mutagenesis and expressed in E. coli (for purification) and mammalian cells (Cos-1, Huh7).
  • Localization & Binding: Live-cell imaging and subcellular fractionation (soluble vs. chromatin-bound) were used to assess nuclear localization and chromatin loading.
  • Enzymatic Assays: In vitro HAT assays (using histone H4 substrate) and autoacetylation assays were conducted to measure catalytic activity.
  • Functional Assays: Huh7 cells were treated with doxorubicin (DNA damage). qPCR was used to measure p21 transactivation, and cell survival assays assessed viability under genotoxic stress.

3. Key Contributions

• Discovery of Allosteric Mechanism: The study reveals that chromodomain mutations can allosterically impair the catalytic MYST domain without disrupting chromatin binding, challenging the dogma that chromodomain mutations solely affect localization.
• Trimerization as a Prerequisite: It establishes that TIP60 must form a trimeric oligomer to effectively bind acetyl-CoA and perform catalysis.
• Specific Mutation Impact: It identifies two specific oncogenic mutations, R53H and R62W, and delineates their distinct structural consequences:
  • R62W: Destabilizes the trimeric interface, altering the acetyl-CoA binding pocket geometry.
  • R53H: Preserves trimerization but induces conformational instability that likely hinders cofactor docking or catalysis.

4. Key Results

• Mutation Identification: Six recurrent chromodomain mutations were identified; R53H and R62W were selected as highly deleterious and pathogenic based on computational consensus and evolutionary conservation.
• Conformational Destabilization (MD Simulations):
  • Both mutants showed increased RMSD (structural drift) and reduced Rg (compacted but unstable fold) compared to WT.
  • Mutants formed more internal hydrogen bonds, suggesting a "locked" but dysfunctional compact state, with increased local flexibility (RMSF) at specific residues.
• Intact Localization, Impaired Catalysis:
  • Localization: Both R53H and R62W mutants localized to the nucleus and formed foci indistinguishable from WT.
  • Chromatin Binding: Subcellular fractionation confirmed that mutants loaded onto chromatin at levels comparable to WT.
  • Enzymatic Defect: Despite intact binding, both mutants exhibited significantly reduced HAT activity (acetylation of H4 K5, K8, K12, K16) and autoacetylation. The R62W mutant showed a more severe defect.
• Structural Basis of Catalytic Failure:
  • Oligomerization: While both mutants could form trimers, the R62W mutation altered the inter-monomer interface residues, shifting the binding interface.
  • Cofactor Docking:
    • WT & R53H: Showed strong binding to acetyl-CoA (CDocker energy ~ -100 kcal/mol).
    • R62W: Showed severely weakened binding (CDocker energy dropped to -52.22 kcal/mol) due to disrupted hydrogen bonding and hydrophobic contacts at the cofactor pocket.
• Functional Consequences in Cells:
  • p21 Transactivation: Under doxorubicin-induced DNA damage, WT TIP60 upregulated p21 expression. Both mutants failed to induce p21.
  • Cell Survival: Cells expressing R53H or R62W mutants were significantly more sensitive to doxorubicin-induced death compared to WT-expressing cells, indicating a failure in DNA damage response (DDR).

5. Significance

• Novel Mechanism of Tumorigenesis: The study provides a mechanistic link between chromodomain mutations and genomic instability. It demonstrates that cancer progression can be driven by mutations that decouple chromatin engagement from enzymatic output.
• Interdomain Communication: It highlights a critical allosteric communication network between the N-terminal chromodomain and the C-terminal MYST domain, mediated by the intrinsically disordered region (IDR) and oligomerization state.
• Therapeutic Implications: Understanding that these mutations act via allosteric destabilization rather than simple loss of binding suggests that therapeutic strategies might need to focus on stabilizing the TIP60 trimeric interface or restoring cofactor docking, rather than just enhancing chromatin recruitment.
• Broader Impact: This work redefines the functional role of chromodomains in reader proteins, suggesting they are not merely "address labels" for chromatin but are integral to the structural integrity and catalytic competence of the protein complex.